# ELAHERE

NDC: 72903-853
Generic name: MIRVETUXIMAB SORAVTANSINE
Labeler / Manufacturer: ImmunoGen, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20221114

FDA application: BLA761310

## Active ingredients

- MIRVETUXIMAB SORAVTANSINE: 5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72903-853"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72903-853
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=00c424b5-6ccd-48ab-9e88-1986451120e2